Crossmark

Stability-indicating method development and validation for the concurrent determination of darunavir, cobicistat, emtricitabine and tenofovir alafenamide by UPLC in bulk and tablet dosage forms

Crossref DOI link: https://doi.org/10.1186/s43094-021-00384-3

Published Online: 2021-12-07

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Satya Venkata Sakuntala, M. https://orcid.org/0000-0003-0836-3087
Lakshmana Rao, A.

William Carey, M.
License Information

Text and Data Mining valid from 2021-12-01

Version of Record valid from 2021-12-07
More Information

Article History

Received: 29 June 2021

Accepted: 24 November 2021

First Online: 7 December 2021

Declarations

:

: Not applicable.

: Not applicable.

: Authors declare that they have no competing interests.

Document is current

Any future updates will be listed below